| Literature DB >> 31546701 |
Galit Katarivas Levy1, Mark A Birch2, Roger A Brooks3, Suresh Neelakantan4,5, Athina E Markaki6.
Abstract
There is currently an interest in "active" implantable biomedical devices that include mechanical stimulation as an integral part of their design. This paper reports the experimental use of a porous scaffold made of interconnected networks of slender ferromagnetic fibers that can be actuated in vivo by an external magnetic field applying strains to in-growing cells. Such scaffolds have been previously characterized in terms of their mechanical and cellular responses. In this study, it is shown that the shape changes induced in the scaffolds can be used to promote osteogenesis in vitro. In particular, immunofluorescence, gene and protein analyses reveal that the actuated networks exhibit higher mineralization and extracellular matrix production, and express higher levels of osteocalcin, alkaline phosphatase, collagen type 1α1, runt-related transcription factor 2 and bone morphogenetic protein 2 than the static controls at the 3-week time point. The results suggest that the cells filling the inter-fiber spaces are able to sense and react to the magneto-mechanically induced strains facilitating osteogenic differentiation and maturation. This work provides evidence in support of using this approach to stimulate bone ingrowth around a device implanted in bone and can pave the way for further applications in bone tissue engineering.Entities:
Keywords: fiber networks; human osteoblasts; in vitro osteogenesis; magneto-mechanical actuation; mineralization
Year: 2019 PMID: 31546701 PMCID: PMC6833056 DOI: 10.3390/jcm8101522
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
In vitro cell mechanotransduction studies carried out during the past five years (2019–2014). Bone marrow mesenchymal stem cells, BMSCs; bone marrow-derived mesenchymal progenitor cells, BMPCs; h, human; r, rat; mouse, m; murine embryonic stem cells, mESC; human acute monocytic leukemia cell line, THP-1; human embryonic stem cell-derived mesenchymal progenitors, hES-MP.
| Scaffold | Cell Type | Stimulation Device | Mechanical Stimulation | Effect of Mechanical Stimulation on Bone-Related Transcriptions, Growth Factors, and Proteins | Ref |
|---|---|---|---|---|---|
| PU foam | hES-MP | Perfusion bioreactor | Flow rate: 3.47 mL·min−1 | [ | |
| PCL-TCP | hBMSC | Perfusion bioreactor | Cyclic compression: 0.22%, 1 Hz, 4 h per day. | Combination of cyclic compression and biaxial rotation showed upregulation of | [ |
| PCL | MC3T3-E1 | Loading device | Compression at 10 millistrain, 1 Hz, 0.5 h and 2 h for 4/8/12 days | [ | |
| Chitosan-HA super-porous hydrogel | hBMSC & THP-1 | Perfusion bioreactor | Bidirectional perfusion, flow rate of 6 mL·h−1, 28 days | [ | |
| HA-PLG | hBMSC | Perfusion bioreactor and XYZ shaker | Continuous perfusion at 3 mL·min−1 or XYZ shaker, 30 rpm, max tilt angle of 4.5° | [ | |
| PU-based meniscus | rBMSC | Perfusion bioreactor | Flow rate of 10 mL·min−1 and hydrodynamic pressure (2 s per cycle) at 10 mL·min−1, 0.5 Hz, at hydraulic pressure: 0–60 or 0–120 mmHg. | [ | |
| Gelatin-coated porous polyurethane | hBMPC | Perfusion bioreactor | Single perfusion session for 2 h, flow rate of 2.5 mL·min−1 on day 5 or 7. | [ | |
| PU-based | hBMSC | Perfusion bioreactor | Perfusion at 10 mL·min−1 with 10% cyclic compression 0.5 or 5 Hz. | [ | |
| Octacalcium phosphate and gelatin | mBMSC | Loading device | Cyclic compressive strains of 20, 40, and 60%, 0.75 Hz, 4 h for 3 or 7 days. | [ | |
| Collagen I | rBMSC | A piezo-type mechanical stimulator | Sinusoidal compressive deformation, 0.2% at 0.2, 2, 10, 20, 40, 60 Hz, 3 min per day. | Ca deposition (optically monitored) increased on days 5–7 and reached the highest value for 2 Hz (1.5-fold) on day 14. | [ |
| Collagen I | mESC | Loading device (six-well loading plate) | 5% cyclic compressive strain, 1 Hz, 2 loading cycles, 4 h followed by 16-h rest (total: 40 h). | [ | |
| PLGA | hMSC | Bioreactor | Dynamic tensile stimulation: 1% strain at 1 Hz for 90 min twice daily for 28 days. | [ | |
| PCL | MC3T3-E1 | Perfusion bioreactor | Computational fluid dynamic (CFD) analysis: flow rate of 1 mL·h−1, wall shear stress 3 Pa. | [ | |
| Partially deproteinized bone | Osteoblast-like rat osteosarcoma cells (ROS17/2.8) | 3D fluid flow cell culture system | Shear stress of 0.8 Pa, loading for 1 h/2 h/4 h followed by statically incubated for 23 h/22 h/20 h. | [ | |
| Collagen hydrogel | hMSCs | Magnetic Force Bioreactor | Magnetic | 2.4-fold increase in mineralization and matrix density | [ |
| Collagen I | mESCs | Loading device (six-well loading plate) | 5% cyclic compressive strain, 1 Hz, 2 loading cycles, 4 h followed by 16-h rest (total: 40 h). | [ |
Figure 1(a) Schematic representations of the elastic deformation of a fiber network under a magnetic field B. Also shown is the deflection of a bonded pair of fibers deforming in-growing bone tissue. (b) Representative relative net extension in the direction of the applied field as a function of the applied magnetic field B for 444 and 316L fiber networks (rectangular beam sample clamped at one end).
Fiber volume fractions, cross-sectional shapes and mean fiber inclination angles (angle between the fiber axis and the through-thickness direction) for 444 and 316L networks [41,42].
| Fiber Network | Fiber Volume Fraction (%) | Fiber Cross-Sectional Shape | Mean Fiber Inclination Angle to the Vertical (°) |
|---|---|---|---|
| 444 | 15.7 ± 1.0 | Rectangular (60 × 100 µm2) | 81.87 ± 0.21 |
| 316L | 15.4 ± 0.9 | Hexagonal (side length 20 µm, diagonal length 40 µm) | 83.49 ± 0.09 |
Figure 2(a) 444 and 316L fiber networks, cut in a keyhole shape, for magnetic actuation. (b,c) Views of the lid and base of the bespoke culture plates. The lid contains tongues (red) to grip the samples, the latter are resting on grooves (blue) at the well mid-height.
Figure 3Representative immunofluorescence images showing magnetically-actuated (M) and static (S) 444 fiber networks on day (a) 16 and (b) 21 of culture. FITC-phalloidin and DAPI were used to stain the actin cytoskeleton green and the nuclei blue, respectively.
Figure 4Fluorescence imaging of mineralization obtained using the OsteoImage Mineralization Assay, for 444 actuated and non-actuated networks on days (a) 16 and (b) 21 of culture. OsteoImage is a fluorescent assay that stains bone-like minerals (including hydroxyapatite) in green and DAPI (blue) was used to counter-stain the fixed cells. (c) Quantification of relative staining intensities on day 21 day for all the tested groups using ImageJ. Bars represent the mean ± standard error for each tested group (n = 3 independent experiments). Statistical analysis was conducted by unpaired t test, *** p < 0.001, ns: no statistical significance.
Figure 5(a) Fluorescence imaging of calcium-rich deposits, stained with Alizarin red, of 444 actuated and non-actuated networks on days 16 and 21 of culture. Red areas indicate positive staining for calcium-rich deposits. (b) Calcium concentration on days 16 and 21 for all the tested groups measured from the released Alizarin red stain using a plate reader at 405 nm. Bars represent the mean ± standard error for each tested group (n = 3). Statistical analysis was conducted by unpaired t test, * p < 0.05, *** p < 0.001, ns: no statistical significance.
Figure 6RT-PCR analysis of osteogenic gene expression of human osteoblasts after 21 days of culture for (a) 444 and (b) 316L fiber networks. The networks were cultured statically for 7 days followed by a daily actuation for 14 days using a magnetic field varying from 0.3 to 1.1 Tesla at a frequency of 0.2 Hz for 5 h. Boxes show interquartile ranges, horizontal lines within the boxes indicate the median, + shows the mean and whiskers denote minimum and maximum values (n = 3, 3 samples for each group per experiment). Data are reported in an x-fold expression of static cultures. Statistical analysis was conducted by unpaired t test, * p < 0.05, *** p < 0.001, **** p < 0.0001, ns: no statistical significance. Osteocalcin, OCN; alkaline phosphatase, ALP; collagen type 1α1, COL1A1; runt-related transcription factor 2, Runx2; bone morphogenetic protein 2, BMP-2; vascular endothelial growth factor, VEGF.
Figure 7ELISA quantification of bone protein concentration in cell culture supernatant by human osteoblasts on day 21 of culture: (a) OCN and (b) BMP-2. Boxes show interquartile ranges, horizontal lines within the boxes indicate the median, + shows the mean and whiskers denote minimum and maximum values (n = 3, 2 samples for each group per experiment). Statistical analysis was conducted by unpaired t test, * p < 0.05, ** p < 0.01, ns: no statistical significance.